Mass General Heart Center researchers detected early changes to the heart muscle using a novel heart ultrasound technique in breast cancer patients. The team was evaluating whether a more sensitive heart ultrasound measurement, as well as additional blood tests, could predict future cardiac toxicity in patients being treated with chemotherapy. The results of the study were announced at the 21st Annual Scientific Sessions of the American Society of Echocardiography.
Read the full news release about this study lead by Massachusetts General Hospital Heart Center cardiologist Heloisa Sawaya, MD.
Browse the Entire Newsroom Archive
Back to Top